Impact of renal disease on elective shoulder arthroplasty outcomes for glenohumeral osteoarthritis

Renal disease including chronic renal disease and end-stage renal disease has been associated with the development of primary glenohumeral osteoarthritis. However, little is known about how renal disease affects outcomes after shoulder arthroplasty. Thus, the purpose of this study was to evaluate th...

Full description

Saved in:
Bibliographic Details
Published in:Seminars in arthroplasty 2022-06, Vol.32 (2), p.297-304
Main Authors: Hsiue, Peter P., Sekimura, Troy, Ocampo, Alfonso, Chen, Clark J., Olson, Thomas E., Kelley, Benjamin V., Photopoulos, Christos, Stavrakis, Alexandra I.
Format: Article
Language:English
Subjects:
Chronic renal disease
Clinical outcomes
Database study
End-stage renal disease
Glenohumeral osteoarthritis
Renal disease
Shoulder arthroplasty
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Renal disease including chronic renal disease and end-stage renal disease has been associated with the development of primary glenohumeral osteoarthritis. However, little is known about how renal disease affects outcomes after shoulder arthroplasty. Thus, the purpose of this study was to evaluate the impact of renal disease on outcomes of shoulder arthroplasty for glenohumeral osteoarthritis. This was a retrospective review using the Nationwide Readmissions Database. Using International Classification of Diseases, 9th Revision, codes, patients who underwent shoulder arthroplasty (including total shoulder arthroplasty and reverse total shoulder arthroplasty) for primary glenohumeral osteoarthritis were identified. These patients were divided into 3 groups: no renal disease, predialysis chronic renal disease (including stages 1-5), and end-stage renal disease. Primary outcomes of interest included the risk of complications during index hospitalization as well as within 90 days of index surgery. Secondary outcomes included index hospitalization length of stay, cost, and discharge location. From 2010 to 2014, a total of 29,336 patients underwent shoulder arthroplasty for glenohumeral osteoarthritis. Of these 29,336, 27,928 (95.2%) patients had no renal disease, 1355 (4.6%) had predialysis chronic renal disease, and 53 (0.2%) patients had end-stage renal disease. Compared with patients with no renal disease, both predialysis chronic renal disease and end-stage renal disease patients had an increased risk of receiving blood transfusions (odds ratio [OR] = 2.04, P 
ISSN:1045-4527
1558-4437
DOI:10.1053/j.sart.2021.11.001